Home brain zapper tested for cancer fog
NCT ID NCT07112521
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a home-use device that sends a mild electrical current to the brain can help breast cancer survivors with memory and attention problems (often called 'chemo brain'). Forty women who finished cancer treatment will use either the active device or a sham version for six weeks. Researchers will also check if being overweight changes how well the treatment works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcranial Direct Current Stimulation (tDCS) device
What this could lead to
If it works, this could offer a safe, at-home way to improve memory and attention in breast cancer survivors struggling with 'chemo brain'.
What could go wrong
This is a small early-stage trial (40 people) testing a mild brain stimulation technique. The effect may be small or no better than placebo, and results may not apply to all survivors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Psychology, Faculty of Medicine, University of Helsinki
RECRUITINGHelsinki, Uusimaa, 00200, Finland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact